Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2025
Unlocking the Potential: Antihistamine Use and Breast Cancer Risk in Women With Type 2 Diabetes MellitusKang-Chuang Chai, Ta-Chun Chou, Wan-Ming Chen, et al.Diabetes & Metabolism|September 28, 2022
Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitusSzu-Yuan Wu, Wan-Ming Chen, Yi-Chan Chen, et al.Journal of Critical Care|May 4, 2025
Sepsis on dementia risk: A population-based cohort study with dose-dependent analysisMingyang Sun, Fangfang Li, Yangyang Wang, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 24, 2025
Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 DiabetesTse-Hsi Li, Jr-Shiang Shiu, Wan-Ming Chen, et al.Diabetes, Obesity & Metabolism|December 17, 2024
Metformin lowers risk of hearing loss and mortality in type 2 diabetesChun-Chih Huang, Rui-Fong Hsu, Wan-Ming Chen, et al.Cancers|July 9, 2022
Effect of Pre-Existing Sarcopenia on Oncological Outcomes for Oral Cavity Squamous Cell Carcinoma Undergoing Curative Surgery: A Propensity Score-Matched, Nationwide, Population-Based Cohort StudyYu-Hsiang Tsai, Wan-Ming Chen, Ming-Chih Chen, et al.BMJ Open Diabetes Research & Care|July 22, 2025
Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetesMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Diabetes, Obesity & Metabolism|May 7, 2025
Long-term delirium and survival outcomes in patients treated with GLP-1 receptor agonists versus metformin in type 2 diabetes: A population-based cohort studyMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Diabetes Research and Clinical Practice|May 22, 2025
Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational studyMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Journal of the American Medical Directors Association|February 14, 2025
Statins Reduce Delirium Risk in Older Adults With Type 2 DiabetesMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Pageof 12